In Brief: Bard's Telescope
This article was originally published in The Gray Sheet
Bard's Telescope: Single-operator, over-the-wire balloon catheter is approved by FDA for use in coronary angioplasty. The company says it plans a domestic launch of the product in early 1998 and outside the U.S. "when production volumes permit." Components in the device shaft facilitate length adjustment of the catheter while "anti-backbleed" and "wirelock" features help prevent blood loss during angioplasty procedures, Bard claims...
You may also be interested in...
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.
Developing biosimilar orphan drugs is fraught with challenges and needs buy-in from regulators, developers, patients and clinicians.